Immunoassay News and Research

RSS
SARS-CoV-2 antibodies in breast milk: Study

SARS-CoV-2 antibodies in breast milk: Study

5.6% seroprevalence of SARS-CoV-2 antibodies in England during second wave

5.6% seroprevalence of SARS-CoV-2 antibodies in England during second wave

Study reports on COVID-19 vaccine uptake and antibody prevalence in England during May 2021

Study reports on COVID-19 vaccine uptake and antibody prevalence in England during May 2021

An assay capable of detecting SARS-CoV-2 antibodies in breast milk and other samples

An assay capable of detecting SARS-CoV-2 antibodies in breast milk and other samples

A rapid, highly accurate test to detect antibodies against SARS-CoV-2 in human serum

A rapid, highly accurate test to detect antibodies against SARS-CoV-2 in human serum

Rapid COVID-19 antibody detection with time‐resolved fluorescence immunoassay

Rapid COVID-19 antibody detection with time‐resolved fluorescence immunoassay

Study evaluates neutralizing antibody responses elicited by the Pfizer/BioNTech COVID-19 vaccine

Study evaluates neutralizing antibody responses elicited by the Pfizer/BioNTech COVID-19 vaccine

Frequent testing improves the detection of SARS-CoV-2

Frequent testing improves the detection of SARS-CoV-2

Antibody development against SARS-CoV-2 following Moderna vaccine

Antibody development against SARS-CoV-2 following Moderna vaccine

Research suggests people living with HIV/AIDS may be less susceptible to SARS-CoV-2

Research suggests people living with HIV/AIDS may be less susceptible to SARS-CoV-2

Scientists detect delayed and reduced antibody responses after BioNTech/Pfizer COVID-19 vaccination in older adults

Scientists detect delayed and reduced antibody responses after BioNTech/Pfizer COVID-19 vaccination in older adults

What are the challenges of SARS-CoV-2 serosurveillance in COVID-19 vaccine recipients?

What are the challenges of SARS-CoV-2 serosurveillance in COVID-19 vaccine recipients?

Beckman Coulter launches new Access AMH Advanced assay to predict poor ovarian response

Beckman Coulter launches new Access AMH Advanced assay to predict poor ovarian response

Study shows CoronaVac to have high seroconversion rate after 40 days

Study shows CoronaVac to have high seroconversion rate after 40 days

Pirfenidone significantly reduces a marker of heart muscle scarring

Pirfenidone significantly reduces a marker of heart muscle scarring

Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?

Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?

Population-based study shows the persistence of neutralizing antibodies against coronavirus

Population-based study shows the persistence of neutralizing antibodies against coronavirus

New study shows large within- and between-assay variation for ß-CTX measurement

New study shows large within- and between-assay variation for ß-CTX measurement

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

Saliva-based testing as a method for monitoring population immunity to SARS-CoV-2 infection

Saliva-based testing as a method for monitoring population immunity to SARS-CoV-2 infection